Jeffrey A. Singer In September 2023, a Food and Drug Administration (FDA) advisory panel informed the agency that, 50 years after...
Read moreAlex Nowrasteh My colleagues and I have spent much time addressing the arguments raised by those who favor further restricting...
Read moreJeffrey Miron and Jacob Winter Libertarians believe that drug prohibition is costly and ineffective. Prohibition encourages violence, since participants in banned...
Read moreChris Edwards In 2025, the new Congress and incoming Trump administration should reassess the sprawling 2022 Inflation Reduction Act (IRA),...
Read moreJustin Logan The Washington foreign-policy establishment, working in concert with the Europeans, has been trying for years to “Trump-proof” both...
Read moreColin Grabow Only weeks after the release of a new study quantifying the high cost of Buy American Act protectionism,...
Read moreDavid J. Bier Among the rampant absurdities about immigration that spread from both the obscure and prominent corners of the...
Read moreJeffrey A. Singer As philosopher Jessica Flanigan pointed out in her book Pharmaceutical Freedom, autonomous adults have the fundamental right...
Read moreMichael Chapman Many Western leaders, such as President Joe Biden and British Prime Minister Keir Starmer, say NATO expansion, including...
Read moreEmma Hopp On October 6, Brazil held its municipal elections. Over 150 million citizens—a number that is roughly 40 percent...
Read moreDisclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 TopStocksInsider. All Rights Reserved.